Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 71437-71439 [2014-28343]

Download as PDF Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices IV. Paperwork Reduction Act of 1995 This guidance refers to currently approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501– 3520) (the PRA). The collections of information in 21 CFR part 801 are approved under OMB control number 0910–0485 and the collections of information in 21 CFR part 610, subpart G, are approved under OMB control number 0910–0338. The labeling provisions recommended in this guidance are not subject to review by OMB because they do not constitute a ‘‘collection of information’’ under the PRA. Rather, the recommended labeling is a ‘‘public disclosure of information originally supplied by the Federal Government to the recipient for the purpose of disclosure to the public’’ (5 CFR 1320.3(c)(2)). V. Comments Interested persons may submit either electronic comments regarding this document to http://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http:// www.regulations.gov. Dated: November 25, 2014. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2014–28265 Filed 12–1–14; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–1936] Establishment of a Public Docket; Electronic Cigarettes and the Public Health Workshop rljohnson on DSK3VPTVN1PROD with NOTICES AGENCY: Food and Drug Administration, HHS. Notice; establishment of docket; request for data, information, and comments. ACTION: The Food and Drug Administration (FDA), Center for Tobacco Products, is establishing a SUMMARY: VerDate Sep<11>2014 15:30 Dec 01, 2014 Jkt 235001 public docket in conjunction with the first public workshop to gather scientific information about electronic cigarettes (e-cigarettes) as announced in Docket No. FDA–2014–N–0001–0079. Regardless of attendance at the public workshop, interested parties are invited to submit comments, supported by research and data, regarding electronic cigarettes and the public health. DATES: Submit written or electronic comments by April 15, 2015. ADDRESSES: Submit electronic comments to http:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center for Tobacco Products, Food and Drug Administration, Document Control Center, Bldg. 71, Rm. G335, 10903 New Hampshire Ave., Silver Spring, MD 20993–0002, 1–877–287–1373, email: workshop.CTPOS@fda.hhs.gov. I. Background On September 17, 2014, FDA announced a public workshop to gather information about e-cigarettes and the public health (Electronic Cigarettes and the Public Health; Public Workshop; 79 FR 55815, September 17, 2014, Docket No. FDA–2014–N–0001). The focus of the workshop is product science (specifically device designs and characteristics, and e-liquid and aerosol constituents), product packaging, constituent labeling, and environmental impact. FDA intends to follow the first workshop with two additional ecigarette workshops; one on individual health effects and one on population health effects. As stated in the Federal Register notice of the public workshop, the workshops are not intended to inform the Agency’s deeming rulemaking. The workshops are intended to better inform FDA about these products. Should the Agency move forward as proposed to regulate ecigarettes, additional information about the products would assist the Agency in carrying out its responsibilities under the law. II. Submission of Comments Regardless of attendance at the public workshop, interested parties are invited to submit comments, supported by research and data, regarding e-cigarettes and the public health. Information related to workshop presentations and PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 71437 discussion topics, including specific questions to be addressed at the workshop, can be found at http:// www.fda.gov/TobaccoProducts/ NewsEvents/ucm238308.htm. Interested persons may submit either electronic comments to this docket at http://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http:// www.regulations.gov. Dated: November 25, 2014. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2014–28261 Filed 12–1–14; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Health Resources and Services Administration (HRSA) has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. DATES: Comments on this ICR should be received no later than January 2, 2015. ADDRESSES: Submit your comments, including the Information Collection Request Title, to the desk officer for HRSA, either by email to OIRA_ submission@omb.eop.gov or by fax to 202–395–5806. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443–1984. SUMMARY: E:\FR\FM\02DEN1.SGM 02DEN1 71438 Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices SUPPLEMENTARY INFORMATION: Information Collection Request Title: Data System for Organ Procurement and Transplantation Network OMB No. 0915–0157—Revision. Abstract: Section 372 of the Public Health Service (PHS) Act requires that the Secretary, by contract, provide for the establishment and operation of an Organ Procurement and Transplantation Network (OPTN). This is a request for revisions to current OPTN data collection forms associated with donor organ procurement and an individual’s clinical characteristics at the time of registration, transplant, and follow-up after the transplant. Need and Proposed Use of the Information: Data for the OPTN data system are collected from transplant hospitals, organ procurement organizations, and tissue-typing laboratories. The information is used to indicate the disease severity of transplant candidates, to monitor compliance of member organizations with OPTN rules and requirements, and to report periodically on the clinical and scientific status of organ donation and transplantation in this country. Data are used to develop transplant, donation and allocation policies, to determine whether institutional members are complying with policy, to determine member-specific performance, to ensure patient safety, and to fulfill the requirements of the OPTN Final Rule. The practical utility of the data collection is further enhanced by requirements that the OPTN data must be made available, consistent with applicable laws, for use by OPTN members, the Scientific Registry of Transplant Recipients, the Department of Health and Human Services, and members of the public for evaluation, research, patient information, and other important purposes. Likely Respondents: Transplant programs, organ procurement organizations, histocompatibility laboratories, medical and scientific organizations, and public organizations. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents rljohnson on DSK3VPTVN1PROD with NOTICES Form name Deceased Donor Registration .............................................. Living Donor Registration .................................................... Living Donor Follow-up ........................................................ Donor Histocompatibility ...................................................... Recipient Histocompatibility ................................................. Heart Candidate Registration .............................................. Heart Recipient Registration ................................................ Heart Follow Up (6 Month) .................................................. Heart Follow Up (1–5 Year) ................................................. Heart Follow Up (Post 5 Year) ............................................ Heart Post-Transplant Malignancy Form ............................. Lung Candidate Registration ............................................... Lung Recipient Registration ................................................. Lung Follow Up (6 Month) ................................................... Lung Follow Up (1–5 Year) ................................................. Lung Follow Up (Post 5 Year) ............................................. Lung Post-Transplant Malignancy Form .............................. Heart/Lung Candidate Registration ..................................... Heart/Lung Recipient Registration ....................................... Heart/Lung Follow Up (6 Month) ......................................... Heart/Lung Follow Up (1–5 Year) ........................................ Heart/Lung Follow Up (Post 5 Year) ................................... Heart/Lung Post-Transplant Malignancy Form .................... Liver Candidate Registration ............................................... Liver Recipient Registration ................................................. Liver Follow-up (6 Month–5 Year) ....................................... Liver Follow-up (Post 5 Year) .............................................. Liver Recipient Explant Pathology Form ............................. Liver Post-Transplant Malignancy ....................................... Intestine Candidate Registration .......................................... Intestine Recipient Registration ........................................... Intestine Follow Up (6 Month–5 Year) ................................. Intestine Follow Up (Post 5 Year) ....................................... Intestine Post-Transplant Malignancy Form ........................ Kidney Candidate Registration ............................................ Kidney Recipient Registration .............................................. Kidney Follow-Up (6 Month–5 Year) ................................... Kidney Follow-up (Post 5 Year) ........................................... Kidney Post-Transplant Malignancy Form ........................... Pancreas Candidate Registration ........................................ Pancreas Recipient Registration ......................................... VerDate Sep<11>2014 15:30 Dec 01, 2014 Jkt 235001 PO 00000 Frm 00063 Number of responses per respondent 58 296 296 154 154 131 131 131 131 131 131 65 65 65 65 65 65 63 63 63 63 63 63 136 136 136 136 136 136 41 41 41 41 41 235 235 235 235 235 135 135 Fmt 4703 Sfmt 4703 Total responses 158.2 20.2 59.5 94.8 170.1 30.5 19.3 17.0 73.9 115.2 11.0 39.0 29.6 25.8 97.9 64.6 1.5 0.7 0.3 0.3 1.5 3.1 0.2 88.6 47.5 229.4 254.6 12.2 13.1 4.4 2.7 13.3 13.5 0.6 161.2 71.9 376.3 343.7 17.9 3.5 1.9 E:\FR\FM\02DEN1.SGM 9174 5984 17610 14598 26199 3991 2525 2229 9683 15091 1447 2534 1923 1677 6364 4201 99 46 21 20 97 194 12 12048 6457 31194 34622 1665 1786 182 109 547 553 25 37880 16904 88422 80770 4213 479 259 02DEN1 Average burden per response (in hours) 1.1 1.8 1.3 0.2 0.4 0.9 1.4 0.4 0.9 0.5 0.9 0.9 1.4 0.5 1.1 0.6 0.4 1.1 1.4 0.8 1.1 0.6 0.4 0.8 1.3 1.0 0.5 0.6 0.8 1.3 1.8 1.5 0.4 1.0 0.8 1.3 0.9 0.5 0.8 0.9 1.1 Total burden hours 10091.4 10771.2 22893.0 2919.6 10479.6 3591.9 3535.0 891.6 8714.7 7545.5 1302.3 2280.6 2692.2 838.5 7000.4 2520.6 39.6 50.6 29.4 16.0 106.7 116.4 4.8 9638.4 8394.1 31194.0 17311.0 999.0 1428.8 236.6 196.2 820.5 221.2 25.0 30304.0 21975.2 79579.8 40385.0 3370.4 431.1 284.9 71439 Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Pancreas Follow-up (6 Month–5 Year) ................................ Pancreas Follow-up (Post 5 Year) ...................................... Pancreas Post-Transplant Malignancy Form ...................... Kidney/Pancreas Candidate Registration ............................ Kidney/Pancreas Recipient Registration ............................. Kidney/Pancreas Follow-up (6 Month–5 Year) .................... Kidney/Pancreas Follow-up (Post 5 Year) .......................... Kidney/Pancreas Post-Transplant Malignancy Form .......... Vascular Composite Allograft Candidate Registration ........ Vascular Composite Allograft Recipient Registration .......... Vascular Composite Allograft Recipient Follow Up ............. 135 135 135 13 135 135 135 135 16 16 16 10.4 13.4 0.8 98.5 5.6 33.4 47.9 1.6 0.9 0.9 0.9 1398 1804 108 1280 760 4509 6465 211 15 15 15 1.0 0.5 0.6 0.9 1.1 1.0 0.6 0.4 0.4 1.3 1.0 1398.0 902.0 64.8 1152 836.0 4509.0 3879.0 84.4 6.0 19.5 15.0 Total .............................................................................. * 456 ........................ 460414 ........................ 358092.5 * Total number of OPTN member institutions as of 09/9/2014. Number of respondents for transplant candidate or recipient forms based on number of organ specific programs associated with each form. Jackie Painter, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2014–28343 Filed 12–1–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Health Resources and Services Administration (HRSA) has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. DATES: Comments on this ICR should be received no later than January 2, 2015. ADDRESSES: Submit your comments, including the Information Collection Request Title, to the desk officer for HRSA, either by email to OIRA_ rljohnson on DSK3VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 15:30 Dec 01, 2014 Jkt 235001 submission@omb.eop.gov or by fax to 202–395–5806. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443–1984. SUPPLEMENTARY INFORMATION: Information Collection Request Title: The Health Professions Student Loan (HPSL) and Nursing Student Loan (NSL) Programs: Deferment-HRSA Form 519 and AOR–HRSA Form 501, OMB No. 0915–0044-Extension Abstract: The HPSL Program, as authorized by Public Health Service (PHS) Act sections 721–722, and 725– 735, provides long-term, low-interest loans to students attending schools of medicine, osteopathic medicine, dentistry, veterinary medicine, optometry, podiatric medicine, and pharmacy. The NSL program as authorized by PHS Act sections 835– 842, provides long-term, low-interest loans to students who attend eligible schools of nursing in programs leading to a diploma in nursing, including an associate degree, a baccalaureate degree, or graduate degree in nursing. Need and Proposed Use of the Information: Participating HPSL and NSL schools are responsible for determining eligibility of applicants, making loans, and collecting monies owed by borrowers on their outstanding loans. The Deferment Form (DefermentHRSA Form 519) provides the schools with documentation of a borrower’s PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 deferment status, as detailed for the HPSL program under 42 CFR 57.210 and for NSL under 42 CFR 57.310. The Annual Operating Report (AOR–HRSA Form 501) provides the U.S. Department of Health and Human Services with information from participating schools (including schools that are no longer disbursing loans but are required to report and maintain program records, student records, and repayment records until all student loans are repaid in full and all monies due to the federal government are returned) relating to HPSL and NSL program operations and financial activities. Likely Respondents: Financial Aid Directors working at institutions participating in the HPSL and NSL Programs. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. E:\FR\FM\02DEN1.SGM 02DEN1

Agencies

[Federal Register Volume 79, Number 231 (Tuesday, December 2, 2014)]
[Notices]
[Pages 71437-71439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28343]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission to OMB for 
Review and Approval; Public Comment Request

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the Health Resources and Services Administration 
(HRSA) has submitted an Information Collection Request (ICR) to the 
Office of Management and Budget (OMB) for review and approval. Comments 
submitted during the first public review of this ICR will be provided 
to OMB. OMB will accept further comments from the public during the 
review and approval period.

DATES: Comments on this ICR should be received no later than January 2, 
2015.

ADDRESSES: Submit your comments, including the Information Collection 
Request Title, to the desk officer for HRSA, either by email to 
OIRA_submission@omb.eop.gov or by fax to 202-395-5806.

FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance 
requests submitted to OMB for review, email the HRSA Information 
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.

[[Page 71438]]


SUPPLEMENTARY INFORMATION:
    Information Collection Request Title: Data System for Organ 
Procurement and Transplantation Network OMB No. 0915-0157--Revision.
    Abstract: Section 372 of the Public Health Service (PHS) Act 
requires that the Secretary, by contract, provide for the establishment 
and operation of an Organ Procurement and Transplantation Network 
(OPTN). This is a request for revisions to current OPTN data collection 
forms associated with donor organ procurement and an individual's 
clinical characteristics at the time of registration, transplant, and 
follow-up after the transplant.
    Need and Proposed Use of the Information: Data for the OPTN data 
system are collected from transplant hospitals, organ procurement 
organizations, and tissue-typing laboratories. The information is used 
to indicate the disease severity of transplant candidates, to monitor 
compliance of member organizations with OPTN rules and requirements, 
and to report periodically on the clinical and scientific status of 
organ donation and transplantation in this country. Data are used to 
develop transplant, donation and allocation policies, to determine 
whether institutional members are complying with policy, to determine 
member-specific performance, to ensure patient safety, and to fulfill 
the requirements of the OPTN Final Rule. The practical utility of the 
data collection is further enhanced by requirements that the OPTN data 
must be made available, consistent with applicable laws, for use by 
OPTN members, the Scientific Registry of Transplant Recipients, the 
Department of Health and Human Services, and members of the public for 
evaluation, research, patient information, and other important 
purposes.
    Likely Respondents: Transplant programs, organ procurement 
organizations, histocompatibility laboratories, medical and scientific 
organizations, and public organizations.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information; to search data sources; to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. The total annual burden hours estimated for 
this ICR are summarized in the table below.

                                    Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Form name                Number of     responses per       Total       per response    Total burden
                                    respondents     respondent       responses      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Deceased Donor Registration.....              58           158.2            9174             1.1         10091.4
Living Donor Registration.......             296            20.2            5984             1.8         10771.2
Living Donor Follow-up..........             296            59.5           17610             1.3         22893.0
Donor Histocompatibility........             154            94.8           14598             0.2          2919.6
Recipient Histocompatibility....             154           170.1           26199             0.4         10479.6
Heart Candidate Registration....             131            30.5            3991             0.9          3591.9
Heart Recipient Registration....             131            19.3            2525             1.4          3535.0
Heart Follow Up (6 Month).......             131            17.0            2229             0.4           891.6
Heart Follow Up (1-5 Year)......             131            73.9            9683             0.9          8714.7
Heart Follow Up (Post 5 Year)...             131           115.2           15091             0.5          7545.5
Heart Post-Transplant Malignancy             131            11.0            1447             0.9          1302.3
 Form...........................
Lung Candidate Registration.....              65            39.0            2534             0.9          2280.6
Lung Recipient Registration.....              65            29.6            1923             1.4          2692.2
Lung Follow Up (6 Month)........              65            25.8            1677             0.5           838.5
Lung Follow Up (1-5 Year).......              65            97.9            6364             1.1          7000.4
Lung Follow Up (Post 5 Year)....              65            64.6            4201             0.6          2520.6
Lung Post-Transplant Malignancy               65             1.5              99             0.4            39.6
 Form...........................
Heart/Lung Candidate                          63             0.7              46             1.1            50.6
 Registration...................
Heart/Lung Recipient                          63             0.3              21             1.4            29.4
 Registration...................
Heart/Lung Follow Up (6 Month)..              63             0.3              20             0.8            16.0
Heart/Lung Follow Up (1-5 Year).              63             1.5              97             1.1           106.7
Heart/Lung Follow Up (Post 5                  63             3.1             194             0.6           116.4
 Year)..........................
Heart/Lung Post-Transplant                    63             0.2              12             0.4             4.8
 Malignancy Form................
Liver Candidate Registration....             136            88.6           12048             0.8          9638.4
Liver Recipient Registration....             136            47.5            6457             1.3          8394.1
Liver Follow-up (6 Month-5 Year)             136           229.4           31194             1.0         31194.0
Liver Follow-up (Post 5 Year)...             136           254.6           34622             0.5         17311.0
Liver Recipient Explant                      136            12.2            1665             0.6           999.0
 Pathology Form.................
Liver Post-Transplant Malignancy             136            13.1            1786             0.8          1428.8
Intestine Candidate Registration              41             4.4             182             1.3           236.6
Intestine Recipient Registration              41             2.7             109             1.8           196.2
Intestine Follow Up (6 Month-5                41            13.3             547             1.5           820.5
 Year)..........................
Intestine Follow Up (Post 5                   41            13.5             553             0.4           221.2
 Year)..........................
Intestine Post-Transplant                     41             0.6              25             1.0            25.0
 Malignancy Form................
Kidney Candidate Registration...             235           161.2           37880             0.8         30304.0
Kidney Recipient Registration...             235            71.9           16904             1.3         21975.2
Kidney Follow-Up (6 Month-5                  235           376.3           88422             0.9         79579.8
 Year)..........................
Kidney Follow-up (Post 5 Year)..             235           343.7           80770             0.5         40385.0
Kidney Post-Transplant                       235            17.9            4213             0.8          3370.4
 Malignancy Form................
Pancreas Candidate Registration.             135             3.5             479             0.9           431.1
Pancreas Recipient Registration.             135             1.9             259             1.1           284.9

[[Page 71439]]

 
Pancreas Follow-up (6 Month-5                135            10.4            1398             1.0          1398.0
 Year)..........................
Pancreas Follow-up (Post 5 Year)             135            13.4            1804             0.5           902.0
Pancreas Post-Transplant                     135             0.8             108             0.6            64.8
 Malignancy Form................
Kidney/Pancreas Candidate                     13            98.5            1280             0.9            1152
 Registration...................
Kidney/Pancreas Recipient                    135             5.6             760             1.1           836.0
 Registration...................
Kidney/Pancreas Follow-up (6                 135            33.4            4509             1.0          4509.0
 Month-5 Year)..................
Kidney/Pancreas Follow-up (Post              135            47.9            6465             0.6          3879.0
 5 Year)........................
Kidney/Pancreas Post-Transplant              135             1.6             211             0.4            84.4
 Malignancy Form................
Vascular Composite Allograft                  16             0.9              15             0.4             6.0
 Candidate Registration.........
Vascular Composite Allograft                  16             0.9              15             1.3            19.5
 Recipient Registration.........
Vascular Composite Allograft                  16             0.9              15             1.0            15.0
 Recipient Follow Up............
                                 -------------------------------------------------------------------------------
    Total.......................           * 456  ..............          460414  ..............        358092.5
----------------------------------------------------------------------------------------------------------------
* Total number of OPTN member institutions as of 09/9/2014. Number of respondents for transplant candidate or
  recipient forms based on number of organ specific programs associated with each form.


Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-28343 Filed 12-1-14; 8:45 am]
BILLING CODE 4165-15-P